Health News

Tuesday, April 1, 2014 - 16:00

Approximately 50% of elderly humans experience sleep disorders, with consequences for quality of life and poor health. However, a new study on the fruit fly Drosophila melanogaster suggests that manipulation of the nutrient sensing insulin/IGF (IIS) and TOR (Target of Rapamycin) signalling networks eases age-related decline in sleep quality and duration. The study from researchers at the Max Planck Institute (MPI) for Biology of Ageing in Cologne is published on April 1st in the journal PLoS Biology.


Tuesday, April 1, 2014 - 11:01

A new study done on pregnant women with gestational diabetes as well as type 2 diabetes shows interesting results and possible treatment options for diabetic patients. Pregnant women with diabetes and type 2 diabetes have elevated levels of a  fat metabolite. The presence of this fat metabolite inturn decreases the ability of pancreatic cells to secrete insulin. This pancreatic cell impairment may help to find preventative measures to treat diabetes.


Tuesday, April 1, 2014 - 09:33

Scientists now present a protein that facilitates the control of nerve cells by light. It might be used as a basis of studies of diseases of the nervous system. The ChlocC channelrhodopsin presented now reacts about 10,000 times more sensitively to light than other proteins used so far for switching off nerve cells.


Tuesday, April 1, 2014 - 09:16

New research in The FASEB Journal suggests that molecular function of the "hairless" gene may explain why mutations contribute to the pathogenesis of atrichia with papular lesions, a rare form of hair loss


Tuesday, April 1, 2014 - 09:03

Researchers from Imperial College London and the Hertie Institute, University of Tuebingen have identified a possible mechanism for re-growing damaged nerve fibres in the central nervous system (CNS). This damage is currently irreparable, often leaving those who suffer spinal cord injury, stroke or brain trauma with serious impairments like loss of sensation and permanent paralysis.


Monday, March 31, 2014 - 13:41

Researchers at Karolinska Institutet have discovered that a substance called Vacquinol-1 makes cells from glioblastoma, the most aggressive type of brain tumor, literally explode. When mice were given the substance, which can be given in tablet form, tumor growth was reversed and survival was prolonged. The findings are published in the journal Cell.